BIOMAT Database Logo BIOMAT Database Logo

Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case. 2011

Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Columbia University Graduate School of Arts and Sciences, New York, NY, USA.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068879 Adalimumab A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. Adalimumab-adbm,Adalimumab-atto,Amjevita,Cyltezo,D2E7 Antibody,Humira,Antibody, D2E7
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies
D019693 Hepatitis, Autoimmune A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES. Autoimmune Chronic Hepatitis,Autoimmune Hepatitis,Autoimmune Chronic Hepatitides,Autoimmune Hepatitides,Chronic Hepatitides, Autoimmune,Chronic Hepatitis, Autoimmune,Hepatitides, Autoimmune,Hepatitides, Autoimmune Chronic,Hepatitis, Autoimmune Chronic

Related Publications

Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
May 2019, Gastroenterologia y hepatologia,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
December 2010, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.
May 2012, European journal of clinical pharmacology,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
September 2005, Journal of gastroenterology and hepatology,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
January 2022, American journal of therapeutics,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
[Infliximab-induced hepatitis in a patient with Crohn's disease].
May 2006, Gastroenterologia y hepatologia,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
[Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
March 2009, Anales de pediatria (Barcelona, Spain : 2003),
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
February 2012, Gut,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
[Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].
October 2009, Orvosi hetilap,
Dahlia A Goldfeld, and Elizabeth C Verna, and Jay Lefkowitch, and Arun Swaminath
Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.
November 2011, Inflammatory bowel diseases,
Copied contents to your clipboard!